Across TCGA pan-cancer cohorts, KRTAP10-6 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of KRTAP10-6’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where KRTAP10-6 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KRTAP10-6 is over-expressed in tumor.

LIHC are the cancer types where KRTAP10-6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KRTAP10-6 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Male	All	+0.045	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: KRTAP10-6 RNA expression & survival · all KRTAP10-6 data types